Hillsdale Investment Management’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-12,587
Closed -$102K 652
2024
Q2
$102K Buy
+12,587
New +$91.8K 0.01% 419
2023
Q3
Sell
-82,780
Closed -$454K 602
2023
Q2
$454K Sell
82,780
-165,000
-67% -$1.12M 0.04% 267
2023
Q1
$2.33M Sell
247,780
-23,400
-9% -$258K 0.2% 148
2022
Q4
$3.17M Sell
271,180
-66,220
-20% -$733K 0.27% 134
2022
Q3
$3.76M Buy
+337,400
New +$4.5M 0.34% 115
2014
Q1
Sell
-2,230
Closed -$174K 560
2013
Q4
$174K Buy
+2,230
New +$182K 0.05% 325

Other funds holding HHS

Hillsdale Investment Management's HHS Position: Q3 2024 in Review

Hillsdale Investment Management sold out of Harte-Hanks (HHS) in Q3 2024, closing a stake of 12,587 shares — an estimated $102K sold.

Hillsdale Investment Management first reported a position in HHS in Q4 2013 and held it in 6 quarters. The position peaked at $3.76M in Q3 2022. 25 funds tracked by Wall St. Rank hold HHS as of Q3 2024.

  • Hillsdale Investment Management reported no remaining Harte-Hanks position as of Q3 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 12,587 Harte-Hanks shares in Q3 2024, an estimated $102K.
  • Hillsdale Investment Management first reported a position in Harte-Hanks in Q4 2013 and held it in 6 quarters.
  • Hillsdale Investment Management's Harte-Hanks position peaked at $3.76M in Q3 2022.
  • 25 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2024.

Based on Hillsdale Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.